Page last updated: 2024-10-31

entinostat and Muscular Dystrophy, Duchenne

entinostat has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colussi, C1
Mozzetta, C1
Gurtner, A1
Illi, B1
Rosati, J1
Straino, S1
Ragone, G1
Pescatori, M1
Zaccagnini, G1
Antonini, A1
Minetti, G1
Martelli, F1
Piaggio, G1
Gallinari, P1
Steinkuhler, C1
Steinkulher, C1
Clementi, E1
Dell'Aversana, C1
Altucci, L1
Mai, A1
Capogrossi, MC1
Puri, PL1
Gaetano, C1

Other Studies

1 other study available for entinostat and Muscular Dystrophy, Duchenne

ArticleYear
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Dec-09, Volume: 105, Issue:49

    Topics: Animals; Benzamides; Cells, Cultured; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase 2;

2008